Drug Pricing and Market Access: CMS Update With Rujul Desai

Podcast: Connected With Latham · Latham & Watkins

Opublikowano: 2026-05-13

The Trump administration has advanced many policy initiatives in the drug pricing and market access area, and CMS —the Centers for Medicare & Medicaid Services — is the agency at the heart of many of these efforts. Rujul Desai, Senior Counselor to CMS and former Deputy General Counsel at the Department of Health & Human Services, joins Washington, D.C. partner Chris Schott and associate Danny Machado for an update on key CMS priorities. Rujul also discusses the transition from big law to government and shares practice pointers for engaging with the agency. Also check out our bi-weekly Drug P...